As such, future studies need to explore (i) the significance of SLX4IP and ALT as a driver of tumor progression, (ii) the plasticity inherent in the establishment and preservation of TMM identity, and (iii) the regulatory landscape of SLX4IP and its connections to the signaling pathways listed above. This evidence concerns the gene SLX4IP and neoplasm.